Orexo Acquires Exclusive US Rights to Commercialize deprexis®, A World-leading Digital Therapy to Help Patients Manage the Symptoms of Depression

UPPSALA, Sweden, May 11, 2020 /PRNewswire/ — Orexo AB (publ.) today announces it has acquired the exclusive US rights to GAIA AG’s (GAIA) deprexis®, a digital therapy to help patients manage their symptoms of depression and one of the most researched digital therapies in the world….

Read Full Article